ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 226080 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 226080; 2) Community: the network communities that were significantly associated with the response to NSC 226080; 3) Molecule: the relationships between components within communities and NSC 226080; 4) MDR: the compounds that were significantly associated with the NSC 226080.

NSC Compound Enrichment Correlation
NSC 663249 Triapine 0.0102412012344427 0.20217749
NSC 663790 Null 0.0102412012344427 0.15416179
NSC 683334 Pyrazolo[5,1-c][1,2,4]benzotriazine-3-carbonitrile, 8-chloro-, 5-oxide 0.0102412012344427 0.025474537
NSC 686498 (3S)-3-(2,3,4,6-Tetra-O-pivaloyl-.beta.-D-glucopyranosyloxy)-1-butanol 0.0102412012344427 0.0084137576
NSC 690754 Null 0.0102412012344427 0.34954489
NSC 762148 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)-N'-(3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanth 0.0102412012344427 0.10443352
NSC 111533 Methoxycamptothecin 0.0103070729572494 0.27925602
NSC 305780 Ethanol, compd. with 6-(2-naphthalenylthio)-2,4-quinazolinediamine (1:2) 0.0103070729572494 -0.15454916
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0103070729572494 0.3726374
NSC 610459 Camptothecin Derivative 0.0103070729572494 0.17955004
Total:50  Current:9    [First] [Prev] [Next] [Last]